Aditya K. Gupta
About
In The Last Decade
Aditya K. Gupta
858 papers receiving 24.0k citations
Hit Papers
Peers
Comparison fields: 5 of 203
- Epidemiology 12.8k
- Dermatology 8.3k
- Cell Biology 7.4k
- Immunology 2.9k
- Infectious Diseases 2.5k
Countries citing papers authored by Aditya K. Gupta
This map shows the geographic impact of Aditya K. Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aditya K. Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aditya K. Gupta more than expected).
Fields of papers citing papers by Aditya K. Gupta
This network shows the impact of papers produced by Aditya K. Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aditya K. Gupta. The network helps show where Aditya K. Gupta may publish in the future.
Co-authorship network of co-authors of Aditya K. Gupta
This figure shows the co-authorship network connecting the top 25 collaborators of Aditya K. Gupta. A scholar is included among the top collaborators of Aditya K. Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aditya K. Gupta. Aditya K. Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 20 | |
| 6 | 1 | |
| 7 | 0 | |
| 8 | 1 | |
| 9 | Libtayo® (Cemiplimab-rwlc) Injection for Intravenous Use. | 0 |
| 10 | 1 | |
| 11 | SOTYKTUTM (Deucravacitinib 6-mg Tablets)- A New Agent for the Management of Adult Plaque Psoriasis. | 2 |
| 12 | ZORYVETM (Roflumilast) Cream: A Topical Phosphodiesterase-4 Inhibitor for the Treatment of Psoriasis. | 4 |
| 13 | High prevalence of mixed infections in global onychomycosis | 0 |
| 14 | 23 | |
| 15 | 13 | |
| 16 | Undifferentiated Carcinoma of Larynx of Nasopharyngeal Type | 6 |
| 17 | 1 | |
| 18 | 2 | |
| 19 | 108 | |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.